APUS APIMEDS PHARMACEUTICALS US I
FollowCOM SHS (common), issuer CIK 1894525
7 managers (7 13F filers) reported a position in APUS shares at 2025-12-31, 395,700 shares in all. 3 filers opened a position and 4 filers sold out during the quarter.
- Managers
- 7
- 13F filers
- 7
- New
- 3
- Added
- 3
- Reduced
- 0
- Sold out
- 4
- Shares held by filers
- 395,700
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q4 2025
Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Hemenway Trust Co LLC | 274,000 | $449K | 0.03% | +24,000 | 13F-HRTimeline |
| VANGUARD GROUP INCin group VANGUARD GROUP INC | 58,992 | $96.7K | <0.01% | 0 | 13F-HRTimelineGroup |
| GEODE CAPITAL MANAGEMENT, LLCin group GEODE CAPITAL MANAGEMENT, LLC | 34,888 | $57.2K | <0.01% | +4,134 | 13F-HRTimelineGroup |
| JANE STREET GROUP, LLCin group JANE STREET GROUP, LLC | 27,188 | $44.6K | <0.01% | new | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 582 | $954 | <0.01% | new | 13F-HRTimelineGroup |
| BANK OF AMERICA CORP /DE/in group BANK OF AMERICA CORP /DE/ | 40 | $66 | <0.01% | +11 | 13F-HRTimelineGroup |
| Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T… | 10 | $16 | <0.01% | new | 13F-HRTimelineGroup |